Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c18a07dd0edefe9e7704549cfc2c6ef8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_188a5657948cc13fe5b08352f74b944c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6f5ee1ef869d9701c15915949d64755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f79749e86afce9444a364ab60ca3584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb214d69c84219770da6a4a924008b90 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
filingDate |
2010-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1215463f4303acfd1a2d57fe7ed6066c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe810cc24ae94d7d109c880703e32c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e3b5eb2d4b09e60fce34e89690d839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62a1c9f6f08486890a6b398fd5f68844 |
publicationDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9289417-B2 |
titleOfInvention |
Compounds and methods for the modulation of sulfilimine bond formation |
abstract |
Methods for regulating the formation of a sulfilimine crosslink in a subject by administering a sulfilimine crosslink modulator are disclosed The sulfilimine modulator may inhibit or create a sulfilimine crosslink and maybe useful for treating a disease, such as cancer The sulfilimine crosslink may be between two or more peptides. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10183039-B2 |
priorityDate |
2009-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |